FDA Import Refusal AEK-8219175-8/11/1 — Sanofi-Aventis Deutschland GmbH
The FDA refused shipment AEK-8219175-8/11/1 from Sanofi-Aventis Deutschland GmbH (Germany) on March 4, 2025. The refused product falls under Drugs and Biologics — DUPILUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 4, 2025
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 58ACY02 DUPILUMAB
- Charges
- 75